News
![Regeneron's Leonard Schleifer](https://pharmaphorum.com/wp-content/uploads/2017/03/Leonard-Schleifer.jpg)
Regeneron seeks CheckMate in immuno-oncology play
Regeneron has agreed an all-cash deal to acquire CheckMate Pharmaceuticals, adding immune activator vidutolimod to its cancer immunotherapy pipeline and ending a barren spell for M&A in